Boots has announced it will start prescribing medical cannabis through an online service, marking a first for a UK high street pharmacy. The service, named SureLeaf, will be available to patients in the UK who are aged 25 and older.
Eligible conditions for the online service include chronic pain, anxiety, and insomnia. Patients interested in the service will undergo an online assessment, followed by a review from a clinical team and a video consultation with a consultant.
Boots stated that any prescription will be independently reviewed by a multidisciplinary clinical team, including a second independent consultant, before treatment commences. Patients must have attempted conventional treatments without success before being considered for medical cannabis, and they will receive regular reviews.
Jamie Kerruish, Boots' chief healthcare officer, noted that many people live with ongoing pain for which conventional treatments are insufficient. Dr David Gwynne, medical director of Boots' online service, emphasised that medical cannabis is not suitable for everyone and prescribing decisions will be made carefully on an individual basis, with strong clinical safeguards in place.